Oura targets $3B IPO at $16B valuation

Ava Taylor 08/31/2026

The Smart Ring Revolution: How Oura is Aiming for a $16 Billion Future

The world of wearable technology is buzzing with whispers of massive valuation, and at the forefront of this seismic shift is Oura, the company behind the popular smart ring. Reports indicate that Oura and some of its existing investors are eyeing an ambitious goal: raising up to US$3 billion through an initial public offering, a move that could catapult the health and wellness technology company to an estimated valuation exceeding US$16 billion.

This extraordinary potential is fueled by the accelerating intersection of biometric tracking and personalized well-being. As the demand for data-driven longevity, beauty, and health becomes paramount, biometric devices like Oura are no longer just gadgets; they are becoming essential tools for navigating modern life. Investors are increasingly recognizing the power of personalized health metrics, which attracts significant attention from major technology groups looking to capitalize on the burgeoning wearable market.

Oura’s journey to this potential valuation is built on solid financial growth and impressive market penetration. Following a substantial US$875 million Series E funding round in September 2025, the company reached a valuation of US$11 billion. The trajectory is clearly upward, with revenue projections aiming for US$1.5 billion in 2026—a threefold increase over the US$500 million generated in 2024.

The physical adoption of the technology is equally compelling. By September 2025, Oura had already sold 5.5 million rings, demonstrating a strong consumer appetite for integrated, continuous health monitoring. This success has positioned the company strongly as it prepares for its public debut.

The upcoming IPO process is being handled with the highest level of financial expertise. Oura is collaborating with some of the industry’s most respected investment banks, including Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Co., and Jefferies, ensuring a smooth and strategic listing.

With the confidential filing for an IPO completed in May, the company anticipates being ready to list as early as September. This strategic collaboration signals a confidence that the market is ready to embrace Oura as a dominant force in the future of personalized health technology.